Search Results

December 2021 "Early-stage studies of COVID-19 treatments from the likes of Vir Biotechnology Inc. and vaccine-makers race to test their shots against the variant, the monoclonal antibody sotrovimab from Vir showing preclinical efficacy against all COVID-19 variants, including the delta and omicron mutations, Vir

December 2021 "Ottawa, Ontario, Canada, Nov. 30, 2021 -- Orion Biotechnology, a clinical stage company

June 2022 "Ottawa, Canada, May 10, 2022 — Orion Biotechnology Canada Ltd, a drug discovery and development

July 2022 "Orion Biotechnology and Peptilogics are pursuing AI-driven drug discovery to explore new functional

.- Jan Steyaert, scientific director of the VIB-VUB Center for Structural Biology, Vlaams Instituut Biotechnologie Brusle, Brussels, Belgium, has been named the winner of Brandeis’ 24th Jacob and Louise Gabbay Award in Biotechnology of one of the biggest classes of pharmaceutical targets by combining structural biology and advanced biotechnology

immunology #antibodies #medicine #cancer #innovation #gpcr #synabs #monoclonalantibodies #drugdiscovery #biotechnology

July 19, 2022 07:00 AM Eastern Daylight Time BOSTON--Tectonic Therapeutic, Inc. a pre-clinical stage biotechnology

than three decades of experience leading sales and marketing operations for both global and domestic biotechnology

platform, today announced it has launched Revelar Biotherapeutics, Inc., an independently operated, new biotechnology

pathway of opioid drugs into cellular structures Inversago Pharma will present at BBHIC 2023 Orion Biotechnology

GPCR Jobs Biotechnology and Biological Sciences Doctoral Training Programme Senior QM Manager Director

Orion Biotechnology Completes Discovery of First-in-Class Molecule Against Undrugged GPCR Target in Four

GPCR Jobs Biotechnology and Biological Sciences Doctoral Training Programme Senior QM Manager Director

receptor 3 Industry News New cannabinoid CB1 receptor antagonists disclosed in Inversago patent Orion Biotechnology

Industry News Orion Biotechnology at the AACR 2023.

Clinical Study to Further Evaluate Functional Precision Medicine Platform in Cancer Patients Orion Biotechnology

Learning Model Three GPCR Companies Earn Prestigious Best Places to Work Certification in 2023 Orion Biotechnology

Inês Pinheiro and Oliver Hartley from the Orion Biotechnology team on their recent study on Arylsulfatases

Trends in Biotechnology , 29 (9), 435–442. https://doi.org/10.1016/j.tibtech.2011.04.003 Fowler, D.

Visit in its clinical phase 2b trial with AEF0117 for the treatment of cannabis use disorder Orion Biotechnology

When he moved to Uppsala in the late 1990s to study engineering, it was biotechnology—then on the rise—that

Industry News Orion Biotechnology will be participating in a panel discussion at the LSX World Congress

superior choice for GPCR calcium signalling GPCR: Structural Insights and Role in Drug Discovery Orion Biotechnology

in Upcoming Investor and Industry Conferences Sosei and IPJ to become Nxera Pharma from April Orion Biotechnology

To solve this industry-wide problem, Orion Biotechnology (Orion) is introducing a novel solution driven About Orion Biotechnology Orion’s mission is to unlock the therapeutic potential of previously undruggable For more information, follow Orion Biotechnology on LinkedIn or visit www.orionbiotechnology.com.

in Upcoming Investor and Industry Conferences International Day of Women and Girls in Science Orion Biotechnology

Nature Biotechnology   2003 , 21  (1), 86–89. https://doi.org/10.1038/nbt765 . (24)      Zwier, J.